通过体质指数和心力衰竭状态分层的心房患者的结果
Jean Jacques Noubiap1, Lisa A Kaltenbach2, Karen Chiswell2
1Centre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, Adelaide, Australia; Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
JACC. Advances
|January 20, 2026
概括
肥胖悖论,心力衰竭 (HF) 和心房动 (AF) 患者的生存益处,在非肥胖患者中显示出更高的BMI,但在AF的肥胖患者中没有.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 这是一个很棒的节目,这是一个很棒的节目.
- 肥胖的悖论 肥胖的悖论
- (在超重或肥胖个体中观察到的生存益处) 在心力衰竭 (HF) 和心房动 (AF) 患者中不一致报告.
研究的目的:
- 研究身体质量指数 (BMI) 和心力衰竭 (HF) 状态之间的相互作用对心房动 (AF) 患者的结果的影响.
主要方法:
- 利用了与医疗保险索赔相关的Get With The Guidelines - 心房的注册表 (2013-2021) 的数据.
- 员工调整了考克斯的比例危险模型来分析BMI和结果之间的关联,按HF状态分层 (没有HF,HFpEF/HFmrEF,HFrEF).
- 评估的一年结果包括死亡率,心血管再住院,血栓栓塞和心肌梗塞.
主要成果:
- 在21,850名患者中,增加的BMI与所有HF状态的非肥胖个体的较低死亡率有关.
- 这种生存益处在肥胖和AF患者中没有观察到 (相互作用P = 0.013).
- 心血管再住院,血栓塞栓和心肌梗塞的风险在整个心血管频谱的肥胖和非肥胖患者之间没有显著差异.
结论:
- 较高的BMI与不肥胖的AF患者的生存率改善有关,无论其HF状态如何.
- 这种生存益处不适用于被归类为肥胖的AF患者.
相关概念视频
Heart Failure II: Pathophysiology
783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
Heart Failure Drugs: Diuretics
824
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824
Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227


